Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Eli Lilly
Eli Lilly
Big pharma’s biggest spenders revealed: 2022 edition
EP Vantage
Fri, 04/21/23 - 10:00 am
M&A
R&D
AbbVie
AstraZeneca
Bristol Myers Squibb
Eli Lilly
GSK
JNJ
Merck
Novartis
Pfizer
Roche
Sanofi
AACR: Lilly challenges Amgen, Mirati with early KRAS data, heading for a field 'much less crowded than it seems'
Fierce Biotech
Tue, 04/18/23 - 10:18 pm
Eli Lilly
Amgen
Mirati Therapeutics
KRAS inhibitors
AACR
Lilly to Make Record-Breaking Investment in Indiana Manufacturing Facilities
PR Newswire
Mon, 04/17/23 - 10:52 pm
Eli Lilly
drug manufacturing
Indiana
FDA declines to approve Eli Lilly's bowel disease drug
Yahoo/Reuters
Thu, 04/13/23 - 10:19 pm
Eli Lilly
IBD
FDA
mirikizumab
Bernie Sanders weighs Senate hearing for largest insulin makers
Seeking Alpha
Thu, 04/13/23 - 11:53 am
Bernie Sanders
diabetes
insulin
drug pricing
Eli Lilly
Sanofi
Novo Nordisk
Senate
Eli Lilly Spends Big on First Mounjaro TV Commercial for Diabetes
Xtalks
Fri, 04/7/23 - 01:43 pm
Eli Lilly
Mounjaro
DTC ads
television ads
diabetes
Diabesity drugs and their free ‘contract sales force’
Medical Marketing and Media
Tue, 04/4/23 - 10:12 am
Novo Nordisk
Eli Lilly
diabetes
obesity
telehealth
social media
Mounjaro
Wegovy
Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more
CP Wire
Mon, 04/3/23 - 03:35 pm
CVS Health
Signify Health
M&A
Ferring Pharmaceuticals
Pfizer
Bristol Myers Squibb
Eli Lilly
Novo Nordisk
Boehringer Ingelheim
Jardiance
Ozempic
drug pricing
Eliquis
CMS
Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more
Mon, 04/3/23 - 03:33 pm
CVS Health
Signify Health
M&A
Ferring Pharmaceuticals
Pfizer
Bristol Myers Squibb
Eli Lilly
Novo Nordisk
Boehringer Ingelheim
Jardiance
Ozempic
drug pricing
Eliquis
CMS
Lilly says experimental Alzheimer's drug reduces amyloid in small study
Reuters
Mon, 04/3/23 - 09:54 am
Eli Lilly
Alzheimer's disease
clinical trials
remternetug
Go or no go? Seagen's Padcev eyes FDA approval
EP Vantage
Mon, 04/3/23 - 09:41 am
FDA
AbbVie
Alvotech
Ascendis Pharma
Astellas
AstraZeneca
Biogen
Daiichi Sankyo
Eli Lilly
Ferring Pharmaceuticals
Hugel
Innoviva
Ionis Pharmaceuticals
Lundbeck
Merck
Novo Nordisk
Otsuka
Pfizer
Roche Seagen
Seres Therapeutics
Takeda
UCB
Vertex Pharmaceuticals
CHMP gives thumbs-up for Wegovy use in adolescents, along with nine new drug recommendations
Endpoints
Sun, 04/2/23 - 04:17 pm
EMA
Europe
CHMP
Wegovy
Novo Nordisk
Bimervax
TG Therapeutics
Eli Lilly
Bristol Myers Squibb
Novartis
AstraZeneca
Boehringer Ingelheim and Eli Lilly's Jardiance gets big lift from heart failure indications
Fierce Pharma
Wed, 03/29/23 - 04:01 pm
Boehringer Ingelheim
Eli Lilly
Jardiance
heart failure
Top 10 pharma R&D budgets in 2022
Fierce Biotech
Mon, 03/27/23 - 10:21 pm
R&D
Roche
JNJ
Merck
Pfizer
Novartis
AstraZeneca
Bristol Myers Squibb
Eli Lilly
Sanofi
AbbVie
Eli Lilly to increase investment to $1B into new Irish manufacturing facility — report
Endpoints
Mon, 03/27/23 - 09:55 pm
Eli Lilly
Ireland
drug manufacturing
Novo's high-dose Rybelsus win tees up regulatory filings—and new rivalries
Fierce Pharma
Mon, 03/27/23 - 11:23 am
Novo Nordisk
Rybelsus
diabetes
clinical trials
Eli Lilly
Will Eli Lilly Be a Trillion-Dollar Stock by 2030?
Motley Fool
Thu, 03/23/23 - 11:35 am
Eli Lilly
Mounjaro
Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
PM Live
Wed, 03/22/23 - 10:15 am
Roche
Eli Lilly
Alzheimer's disease
diagnostics
Flare fires up with $123M series B to target transcription factors with 3 Big Pharmas in tow
Fierce Biotech
Wed, 03/22/23 - 10:13 am
Flare Therapeutics
funding
Pfizer
Eli Lilly
Novartis
transcription factors
AACR 2023 – Moderna's immunotherapeutic splash
EP Vantage
Wed, 03/22/23 - 10:03 am
AACR
Moderna Therapeutics
Allogene
AstraZeneca
Merck
Roche
Novartis
Eli Lilly
Innovent
Springworks
Biogene
Relay Therapeutics
Vivace Therapeutics
Pages
« first
‹ previous
…
7
8
9
10
11
12
13
14
15
…
next ›
last »